Topic Hub
5 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 5 of 5 clinical reviews.
A detailed examination of the PIVENS trial's enrollment biases, statistical caveats, generalizability gaps, and what post-publication commentary revealed about vitamin E and pioglitazone for NASH.
Read clinical reviewA detailed breakdown of the PIVENS trial design, randomization, blinding, endpoint definitions, and statistical approach that shaped how we interpret vitamin E and pioglitazone for NASH.
Read clinical reviewA deep-dive into the PIVENS trial's primary and secondary endpoints, effect sizes, confidence intervals, histological response rates, and time-course data for vitamin E and pioglitazone in nonalcoholic steatohepatitis.
Read clinical reviewDetailed breakdown of PIVENS trial subgroup analyses for vitamin E and pioglitazone in NASH, examining responses by age, sex, BMI, baseline ALT, NAS score, and fibrosis stage.
Read clinical reviewA deep-dive overview of the PIVENS trial (2010), the landmark RCT that tested vitamin E and pioglitazone against placebo for nonalcoholic steatohepatitis in adults without diabetes.
Read clinical review